The biotechnology industry has mushroomed since 1992, with U.S. health care biotech revenues from publicly traded companies rising from $8 billion in 1992 to $58.8 billion in 2006.
- For Students
- For Teachers
- Programs
- International BioGENEius Challenge
- Testimonials
- Volunteer Opportunities
- U.S. National BioGENEius Challenge
- Local BioGENEius Challenges
- At-Large BioGENEius Challenge Competition
- Your World Magazine
- About the Institute
- Supporters
- What is Biotechnology?
